<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-30075FE</udiDi>
    <basicUdiDi>B-30075FE</basicUdiDi>
    <tradeName>INTIMOHELP</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Rolf Kullgren AB</manufacturerName>
    <manufacturerSrn>SE-MF-000021108</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>30075</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-24T22:42:19.965Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-40007F8</udiDi>
    <basicUdiDi>B-40007F8</basicUdiDi>
    <tradeName>Canesbalance</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Rolf Kullgren AB</manufacturerName>
    <manufacturerSrn>SE-MF-000021108</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>40007</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-24T19:47:48.339Z</lastUpdated>
  </row>
  <row>
    <udiDi>08058302780603</udiDi>
    <basicUdiDi>B-08058302780603</basicUdiDi>
    <tradeName>Saugella Lavanda di Attiva</tradeName>
    <deviceName>Saugella Lavanda di Attiva</deviceName>
    <manufacturerName>Meda Pharma S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000012233</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N.A.</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T10:07:51.709Z</lastUpdated>
  </row>
  <row>
    <udiDi>08058302780597</udiDi>
    <basicUdiDi>B-08058302780597</basicUdiDi>
    <tradeName>Saugella Lavanda di Attiva</tradeName>
    <deviceName>Saugella Lavanda di Attiva</deviceName>
    <manufacturerName>Meda Pharma S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000012233</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N.A.</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T10:07:47.679Z</lastUpdated>
  </row>
  <row>
    <udiDi>08058302780580</udiDi>
    <basicUdiDi>B-08058302780580</basicUdiDi>
    <tradeName>Saugella lavanda vaginale</tradeName>
    <deviceName>Saugella Lavanda vaginale</deviceName>
    <manufacturerName>Meda Pharma S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000012233</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N.A.</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T10:07:46.884Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.113.1%.S.2Z4</udiDi>
    <basicUdiDi>B-FT.CE.113.1%.S.2Z4</basicUdiDi>
    <tradeName>BORAGYN 1%</tradeName>
    <deviceName>BORAGYN 1%</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.113.1%.S.2</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-23T19:37:28.904Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.113.1%.S.1Z2</udiDi>
    <basicUdiDi>B-FT.CE.113.1%.S.1Z2</basicUdiDi>
    <tradeName>VAGIBOR 1%</tradeName>
    <deviceName>VAGIBOR 1%</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.113.1%.S.1</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-23T19:37:28.108Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.113.1%.S.1.CAMPRP</udiDi>
    <basicUdiDi>B-FT.CE.113.1%.S.1.CAMPRP</basicUdiDi>
    <tradeName>VAGIBOR 1%</tradeName>
    <deviceName>VAGIBOR 1%</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.113.1%.S.1.CAMP</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-23T19:37:27.324Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-8436584761440AW</udiDi>
    <basicUdiDi>B-8436584761440AW</basicUdiDi>
    <tradeName>Melagyn lubrificante floraprotect</tradeName>
    <deviceName>Melagyn lubricante floraprotect 50ml</deviceName>
    <manufacturerName>Green Life srl</manufacturerName>
    <manufacturerSrn>IT-MF-000041188</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>112103</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-22T19:55:03.158Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.116.7CA</udiDi>
    <basicUdiDi>B-FT.CE.116.7CA</basicUdiDi>
    <tradeName>Ilagyn Ovuli</tradeName>
    <deviceName>Ilagyn Ovuli</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.116.7</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-21T21:42:37.466Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.116.6C8</udiDi>
    <basicUdiDi>B-FT.CE.116.6C8</basicUdiDi>
    <tradeName>Marigyn Ovuli</tradeName>
    <deviceName>Marigyn Ovuli</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.116.6</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-21T21:42:36.681Z</lastUpdated>
  </row>
  <row>
    <udiDi>04048882678845</udiDi>
    <basicUdiDi>404888219273DM</basicUdiDi>
    <tradeName>Vagisan kosteuttava emätinvoide kombi</tradeName>
    <deviceName>Vagisan MoistCream Combi</deviceName>
    <manufacturerName>Dr. August Wolff GmbH &amp; Co. KG Arzneimittel</manufacturerName>
    <manufacturerSrn>DE-MF-000005943</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00067884</reference>
    <placedOnMarketCountry>Lithuania</placedOnMarketCountry>
    <lastUpdated>2026-07-17T19:43:43.699Z</lastUpdated>
  </row>
  <row>
    <udiDi>04048882001803</udiDi>
    <basicUdiDi>404888219281DL</basicUdiDi>
    <tradeName>V-san vlažilni Cremolum</tradeName>
    <deviceName>Vagisan MoistCream Cremolum</deviceName>
    <manufacturerName>Dr. August Wolff GmbH &amp; Co. KG Arzneimittel</manufacturerName>
    <manufacturerSrn>DE-MF-000005943</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>00066996</reference>
    <placedOnMarketCountry>Slovenia</placedOnMarketCountry>
    <lastUpdated>2026-07-17T19:43:39.731Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.116.5C6</udiDi>
    <basicUdiDi>B-FT.CE.116.5C6</basicUdiDi>
    <tradeName>Axogyn Ovuli</tradeName>
    <deviceName>Axogyn Ovuli</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.116.5</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T19:36:50.841Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.116.5.CAMP*SE</udiDi>
    <basicUdiDi>B-FT.CE.116.5.CAMP*SE</basicUdiDi>
    <tradeName>Axogyn Ovuli</tradeName>
    <deviceName>Axogyn Ovuli</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.116.5.CAMP*</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T19:36:50.625Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.116.4.CAMP*RV</udiDi>
    <basicUdiDi>B-FT.CE.116.4.CAMP*RV</basicUdiDi>
    <tradeName>Gynè Ovuli</tradeName>
    <deviceName>Gynè Ovuli</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.116.4.CAMP*</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T19:36:49.242Z</lastUpdated>
  </row>
  <row>
    <udiDi>08058302780610</udiDi>
    <basicUdiDi>B-08058302780610</basicUdiDi>
    <tradeName>Saugella gel</tradeName>
    <deviceName>Saugella gel</deviceName>
    <manufacturerName>Meda Pharma S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000012233</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N.A.</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-17T03:29:55.168Z</lastUpdated>
  </row>
  <row>
    <udiDi>08058302780573</udiDi>
    <basicUdiDi>B-08058302780573</basicUdiDi>
    <tradeName>Saugella lavanda vaginale</tradeName>
    <deviceName>Saugella Lavanda vaginale</deviceName>
    <manufacturerName>Meda Pharma S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000012233</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N.A.</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T03:29:54.048Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052990632305</udiDi>
    <basicUdiDi>805299063GINE003H7</basicUdiDi>
    <tradeName>NEILA Gel Vaginale</tradeName>
    <deviceName>Vaginal Gel</deviceName>
    <manufacturerName>Nirial Pharma srl</manufacturerName>
    <manufacturerSrn>IT-MF-000018760</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PZVGVN30</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:42:38.389Z</lastUpdated>
  </row>
  <row>
    <udiDi>08031359064049</udiDi>
    <basicUdiDi>80313596021MZ</basicUdiDi>
    <tradeName>SAGINIL GELIS</tradeName>
    <deviceName>Gel vaginale</deviceName>
    <manufacturerName>Epitech Group SpA</manufacturerName>
    <manufacturerSrn>IT-MF-000031026</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>6404</reference>
    <placedOnMarketCountry>Lithuania</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:41:18.505Z</lastUpdated>
  </row>
</eudamedExport>